Found: 1
Select item for more details and to access through your institution.
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 893, doi. 10.3390/vaccines12080893
- By:
- Publication type:
- Article